Variant report
Variant | esv3425783 |
---|---|
Chromosome Location | chr5:49519095-49526793 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527834291 | chr5:49519801-49519802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574890039 | chr5:49519803-49519804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186969780 | chr5:49519828-49519829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200057221 | chr5:49519843-49519844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74475656 | chr5:49519847-49519848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78633140 | chr5:49519853-49519854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552678740 | chr5:49519896-49519897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111906084 | chr5:49519914-49519915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77699924 | chr5:49519921-49519922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530298871 | chr5:49519943-49519944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560590841 | chr5:49519955-49519956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532156958 | chr5:49519967-49519968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564503408 | chr5:49519970-49519971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545461926 | chr5:49519972-49519973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562279964 | chr5:49519991-49519992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531300247 | chr5:49519999-49520000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148562422 | chr5:49520000-49520001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116237752 | chr5:49520016-49520017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527459156 | chr5:49520022-49520023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144842501 | chr5:49520038-49520039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201980741 | chr5:49520040-49520041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200442725 | chr5:49520048-49520049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116610596 | chr5:49520065-49520066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372823168 | chr5:49520070-49520071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570632303 | chr5:49520091-49520092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376541746 | chr5:49520109-49520110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190944798 | chr5:49520114-49520115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538653067 | chr5:49520122-49520123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568615337 | chr5:49520140-49520141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538346454 | chr5:49520141-49520142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555060926 | chr5:49520149-49520150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530430 | chr5:49520154-49520155 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs112591622 | chr5:49520182-49520183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531198 | chr5:49520185-49520186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs554551587 | chr5:49520195-49520196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577454912 | chr5:49520233-49520234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565931523 | chr5:49520250-49520251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113061084 | chr5:49520265-49520266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201268013 | chr5:49520272-49520273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113641029 | chr5:49520277-49520278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76101372 | chr5:49520291-49520292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146179603 | chr5:49520293-49520294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575588918 | chr5:49520300-49520301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143699223 | chr5:49520303-49520304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200483309 | chr5:49520313-49520314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201778621 | chr5:49520322-49520323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372172119 | chr5:49520335-49520336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375490763 | chr5:49520336-49520337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369688000 | chr5:49520347-49520348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs199501647 | chr5:49520355-49520356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:49519800-49524200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr5:49520600-49520800 | Weak transcription | Psoas Muscle | Psoas |
3 | chr5:49520600-49525000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:49520600-49526200 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
5 | chr5:49520600-49527000 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
6 | chr5:49520800-49521800 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
7 | chr5:49520800-49521800 | ZNF genes & repeats | iPS-18 Cell Line | embryonic stem cell |
8 | chr5:49520800-49526000 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
9 | chr5:49521000-49521200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr5:49521000-49521200 | ZNF genes & repeats | Brain Anterior Caudate | brain |
11 | chr5:49521000-49521200 | ZNF genes & repeats | Fetal Brain Male | brain |
12 | chr5:49521000-49521400 | ZNF genes & repeats | Brain Dorsolateral Prefrontal Cortex | brain |
13 | chr5:49523000-49523600 | ZNF genes & repeats | HUVEC | blood vessel |
14 | chr5:49526400-49526800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |